Ramipril
Ramipril is an elite angiotensin-converting enzyme (ACE) inhibitor prodrug that undergoes hepatic conversion to its active metabolite, ramiprilat. This active form directly inhibits the enzyme responsible for converting angiotensin I into the powerful vasoconstrictor angiotensin II. By downregulating angiotensin II production, it naturally lowers systemic vascular tension, reduces plasma aldosterone secretion to minimize fluid retention, and preserves renal capillary beds in diabetic patients.
Hypertension Management
Cardiovascular Risk Reduction
Heart Failure Support
Hypertension Management
Cardiovascular Risk Reduction
Heart Failure Support
High Purity & Efficacy
USP / BP / EP / IP Grade Compliance
Stringent Quality Control & Batch Consistency
Pharmaceutical Formulations
Oral Solid Dosage (Tablets & Capsules)
Sterile Formulations / Injectables (where applicable)
Custom API Compounding
